表紙
市場調査レポート

医薬品製造、研究開発、包装受託の世界市場

Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging

発行 BCC Research 商品コード 286315
出版日 ページ情報 英文 213 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
医薬品製造、研究開発、包装受託の世界市場 Global Markets for Contract Pharmaceutical Manufacturing, Research and Packaging
出版日: 2015年06月25日 ページ情報: 英文 213 Pages
担当者のコメント
BCC Research社のレポートは、Reuter、Wall Street Journal、Fortuneなどで引用されることも多く、それぞれの業界の識者の意見として重きを置かれています。同社レポートを複数冊ご購入の場合年間パッケージのご契約がお得です。詳細は右の担当者のおすすめ商品よりご覧下さい。
概要

世界の医薬品製造、研究開発、包装受託市場は2014年に2,485億米ドルに達し、今後もCAGR7.3%で拡大し、2019年までに3,528億米ドルに近づくと予測されています。

当レポートでは、世界の医薬品製造、研究開発、包装受託市場の概要と将来的見通し、2019年までの成長率、アウトソーシング、法規制環境、技術面における市場のニーズ、および参入企業の包括的プロファイルをまとめています。

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 概要

  • アウトソーシング
  • 製造受託
  • 研究開発受託機関
  • 包装受託

第4章 法規制の側面

  • 警告書
  • 法規制の認可

第5章 最新開発動向

第6章 市場分析:製造受託

  • バルク薬剤製造受託
  • 剤形製造受託
  • 壊死増受託による最新ドラッグデリバリー製品
  • OTCおよびニュートラシューティカルの製造受託
  • 用途/治療分野別製造受託

第7章 市場分析:研究開発受託

  • 原則別市場
  • 地域別市場
  • 治療分野別市場

第8章 市場分析:包装受託

  • タイプ別市場
  • 地域別市場

第9章 業界構造

  • 製造受託
  • 研究開発受託
  • 包装受託

第10章 特許分析

第11章 現況

  • アウトソーシング市場への影響因子
  • 医薬品アウトソーシング動向

第12章 企業プロファイル

第13章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: PHM043F

REPORT HIGHLIGHTS

The global market for contract pharmaceutical manufacturing, research and packaging totaled $248.5 billion in 2014 and is projected to approach $352.8 billion by 2019, registering a compound annual growth rate (CAGR) of 7.3% through 2019.

This report provides:

  • An overview of the global market for contract pharmaceutical manufacturing, research, and packaging, with emphasis on the current and future outlook of the market and a comprehensive analysis of the overall pharmaceutical and biotechnology outsourcing industry.
  • Analyses of global market trends, with data from 2013 and 2014, and projections of compound annual growth rates (CAGRs) through 2019.
  • Examination of the effects on market growth of state-of-the-art packaging facilities as well as expensive research facilities and the capabilities of research organizations.
  • Coverage of the market's need for outsourcing, the regulatory environment, and technological issues, including the latest trends and developments.
  • Comprehensive company profiles of major players.

SCOPE OF REPORT

The scope of this study covers in-depth analysis of the global contract manufacturing, research and packaging markets. The contract manufacturing market for the pharmaceutical industry is segmented into various dosage forms, over-the-counter (OTC) and nutraceuticals, and drug delivery technologies. Clinical, drug discovery, analytical and other segments of pharmaceutical research through outsourcing have been analyzed under the contract research market. The contract packaging market is segmented into primary, secondary and tertiary packaging. In the primary packaging market, primary containers are categorized as blisters, bottles and a large category of “others,” which includes prefillable syringes, inhalers, vials and ampoules, caps and closures, dosing droppers, and labels and accessories. Analysis of market segments, trends and revenue forecasts for the global, North American and European regions as well as emerging markets have been provided in detail. The emerging market for contract manufacturing includes countries such as India, China, Japan, Korea, Taiwan, Canada, Africa, Australia, New Zealand, etc. BCC Research analyzes each market by its application, its regulatory environment and its technology. This analysis includes market projections and estimating market shares of the players.

ANALYST'S CREDENTIALS

The study has been carried out by a team of professionals in the biotechnology industry. The project manager for this project is Shalini S. Dewan, who holds a master's degree in pharmaceutical chemistry and has over 14 years of industry experience. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S.

Table of Contents

CHAPTER 1 - INTRODUCTION

  • STUDY GOALS AND OBJECTIVES
  • REASONS FOR DOING THE STUDY
  • INTENDED AUDIENCE
  • SCOPE OF REPORT
  • METHODOLOGY AND INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 - EXECUTIVE SUMMARY

  • SUMMARY TABLE: GLOBAL MARKET FOR CONTRACT PHARMACEUTICAL MANUFACTURING, RESEARCH AND PACKAGING BY SEGMENT, THROUGH 2019 ($ BILLIONS)
  • SUMMARY FIGURE: GLOBAL MARKET FOR CONTRACT PHARMACEUTICAL MANUFACTURING, RESEARCH AND PACKAGING BY SEGMENT, 2012-2019 ($ BILLIONS)

CHAPTER 3 - OVERVIEW

  • OUTSOURCING
    • HISTORY OF OUTSOURCING
      • TABLE 1: KEY DEVELOPMENTS IN THE HISTORY OF OUTSOURCING
    • KEY COMPONENTS OF A SUCCESSFUL OUTSOURCING STRATEGY
    • CORE FUNCTIONAL AREAS THAT NEED CONSTANT MONITORING
      • Cost Management
      • Communication Management
      • Performance Management
      • Risk Management
      • Crisis Management
      • Knowledge Transfer Management
      • Relationship Management
  • CONTRACT MANUFACTURING
    • TYPES OF CONTRACT MANUFACTURERS
      • Those Who "Supply"
      • Those Who "Toll"
        • Types of Toll Manufacturers
          • Sellers of Excess Capacity
          • Suitable Service Providers
          • Academic Institutions
    • FOUR STAGES OF CONTRACT MANUFACTURING
      • Program Initiation
      • Service Implementation
      • Final Agreement
      • Program Closure
    • CORE CAPABILITIES OF CMOS
    • REASONS FOR PHARMACEUTICAL CONTRACT MANUFACTURING
      • Reduce and Control Operating Costs
      • Focus on Core Competencies
      • Access to Advanced Technologies
      • Risk Sharing
    • BENEFITS OF CONTRACT MANUFACTURING
    • SUCCESS FACTORS IN CONTRACT MANUFACTURING
      • Product Quality
      • Cost-Competitiveness
      • Delivery Schedule
      • CM/Customer Relationship
    • RISKS IN CONTRACT MANUFACTURING
      • Lack of Control
      • Relationships
      • Quality Concerns
      • Intellectual Property Loss
      • Other Risks
      • Capacity Constraints
      • Loss of Flexibility and Responsiveness
        • TABLE 2: ADVANTAGES AND DISADVANTAGES OF CONTRACT MANUFACTURING
    • SYSTEMIC APPROACH FOR SELECTING A CONTRACT MANUFACTURER
      • Getting the List
      • Make a List
      • Contact CMOs and Create Request for Quote Package
      • Site Visit
      • Negotiation with the Finalists
  • CONTRACT RESEARCH ORGANIZATIONS
    • SERVICES OFFERED BY A CRO
    • BENEFITS OF USING A CRO
    • SELECTING A CRO
    • CLIENT-CRO RELATIONSHIP
    • KEYS FOR A SUCCESSFUL CLIENT-CRO RELATIONSHIP
      • Selecting the Right Partner
      • Avoiding Unclear Expectations and Vague or Conflicting Requirements
      • Avoiding Micro-managing Every Step
      • Setting Realistic Expectations
      • Vendor's Input
      • Expecting a CRO to Replicate Client's Processes
      • Promising Based on Capabilities
      • Understanding the Project's Goals
      • Managing Communications
      • Problem-solving Aptitude
  • CONTRACT PACKAGING
    • TYPES OF PACKAGING
      • Primary Packaging
      • Secondary Packaging
      • Tertiary Packaging
    • REASONS A CONTRACT PACKAGER MIGHT BE NEEDED
    • CHOOSING A CONTRACT PACKAGER
      • Location
      • Relevant Experience
      • Ethics
      • Cost
      • Communication
      • Controls
      • Quality
    • ETHICAL STANDARDS FOR CONTRACT PACKAGERS

CHAPTER 4 - REGULATORY ASPECTS

  • WARNING LETTERS
    • TABLE 3: PHARMACEUTICAL MANUFACTURERS THAT RECEIVED WARNING LETTERS, 2014
    • TABLE 4: PHARMACEUTICAL MANUFACTURERS THAT RECEIVED WARNING LETTERS, 2013
    • TABLE 5: PHARMACEUTICAL MANUFACTURERS THAT RECEIVED WARNING LETTERS, 2012
    • TABLE 6: PHARMACEUTICAL MANUFACTURERS THAT RECEIVED WARNING LETTERS, 2011
  • REGULATORY APPROVALS
    • TABLE 7: REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, 2014
    • TABLE 8: REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, 2013
    • TABLE 9: REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, 2012
    • TABLE 10: REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, 2011

CHAPTER 5 - NEW DEVELOPMENTS

  • ACTAVIS PLC
  • LONZA
  • BRISTOL-MYERS SQUIBB
  • ABBVIE
  • ALBANY MOLECULAR RESEARCH INC.
  • BASF
  • EVOTEC AG
  • HOSPIRA
  • MALLINCKRODT
  • DR. REDDY'S LABORATORIES
  • PERRIGO CO. PLC
  • PATHEON
  • OTHER

CHAPTER 6 - MARKET ANALYSIS: CONTRACT MANUFACTURING

  • CONTRACT MANUFACTURING OF BULK DRUGS/APIS
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 11: GLOBAL REVENUE FOR BULK DRUG/APIS THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 1: GLOBAL REVENUE FOR BULK DRUG/APIS THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS)
  • CONTRACT MANUFACTURE OF DOSAGE FORMS
    • MARKET BY TYPE
      • Market Overview
      • Market Revenue
        • TABLE 12: GLOBAL REVENUE FOR CONTRACT MANUFACTURING OF VARIOUS DOSAGE FORMS, THROUGH 2019 ($ MILLIONS)
        • FIGURE 2: GLOBAL REVENUE FOR CONTRACT MANUFACTURING OF VARIOUS DOSAGE FORMS, 2012-2019 ($ MILLIONS)
    • MARKET BY REGION
      • Solid Dosage Form
        • Market Overview
        • Market Revenue
          • TABLE 13: GLOBAL REVENUE FOR SOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS)
          • FIGURE 3: GLOBAL REVENUE FOR SOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS)
      • Liquid Dosage Forms
        • Market Overview
        • Non-sterile Formulations
        • Sterile Formulations
        • Market Revenue for Non-sterile Formulations
          • TABLE 14: GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (NON-STERILE) THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS)
          • FIGURE 4: GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (NON-STERILE) THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS)
        • Market Revenue for Sterile Formulations
          • TABLE 15: GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (STERILE) THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS)
          • FIGURE 5: GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (STERILE) THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS)
      • Semisolid Dosage Forms
        • Market Overview
        • Market Revenue
          • TABLE 16: GLOBAL REVENUE FOR SEMISOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS)
          • FIGURE 6: GLOBAL REVENUE FOR SEMISOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS)
    • MARKET BY FORMULATIONS
      • Solid Dosage Forms
        • Market Revenue for Solid Dosage Forms
          • TABLE 17: GLOBAL REVENUE FOR SOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ MILLIONS)
          • FIGURE 7: GLOBAL REVENUE FOR SOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ MILLIONS)
        • Market Share of Solid Dosage Formulations
          • TABLE 18: GLOBAL MARKET SHARE OF SOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
          • FIGURE 8: GLOBAL MARKET SHARE OF SOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
      • Liquid Dosage Forms
        • Market Revenue of Non-sterile Forms
          • TABLE 19: GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (NON-STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ MILLIONS)
          • FIGURE 9: GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (NON-STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ MILLIONS)
        • Market Share of Non-sterile Formulations
          • TABLE 20: GLOBAL MARKET SHARE OF LIQUID DOSAGE FORMS (NON-STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
          • FIGURE 10: GLOBAL MARKET SHARE OF LIQUID DOSAGE FORMS (NON-STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
        • Market Revenue for Sterile Formulations
          • TABLE 21: GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ MILLIONS)
          • FIGURE 11: GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ MILLIONS)
        • Market Share of Sterile Formulations
          • TABLE 22: GLOBAL MARKET SHARE OF LIQUID DOSAGE FORMS (STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
          • FIGURE 12: GLOBAL MARKET SHARE OF LIQUID DOSAGE FORMS (STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
      • Semisolid Dosage Forms
        • Market Revenue
          • TABLE 23: GLOBAL REVENUE FOR SEMISOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ MILLIONS)
          • FIGURE 13: GLOBAL REVENUE FOR SEMISOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ MILLIONS)
        • Market Share
          • TABLE 24: GLOBAL MARKET SHARE OF SEMISOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
          • FIGURE 14: GLOBAL MARKET SHARE OF SEMISOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
  • ADVANCED DRUG DELIVERY PRODUCTS THROUGH CONTRACT MANUFACTURING
    • MARKET OVERVIEW
      • TABLE 25: SOME CONTRACTING COMPANIES PROVIDING DRUG-DELIVERY SYSTEMS MARKET BY REGION
      • TABLE 26: GLOBAL REVENUE FOR ADVANCED DRUG DELIVERY SYSTEMS THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 15: GLOBAL REVENUE FOR ADVANCED DRUG DELIVERY SYSTEMS THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS)
    • MARKET BY FORMULATION
      • TABLE 27: GLOBAL REVENUE FOR ADVANCED DRUG DELIVERY SYSTEMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 16: GLOBAL REVENUE FOR ADVANCED DRUG DELIVERY SYSTEMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 28: GLOBAL MARKET SHARE OF ADVANCED DRUG DELIVERY SYSTEMS THROUGH CONTRACT MANUFACTURING BY TYPE, 2013 (%)
      • FIGURE 17: GLOBAL MARKET SHARE OF ADVANCED DRUG DELIVERY SYSTEMS THROUGH CONTRACT MANUFACTURING BY TYPE, 2013 (%)
  • CONTRACT MANUFACTURE OF OTC AND NUTRACEUTICALS
    • MARKET BY REGION
      • Market Revenue
        • TABLE 29: GLOBAL REVENUE FOR OTC AND NUTRACEUTICALS THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ BILLIONS)
        • FIGURE 18: GLOBAL REVENUE FOR OTC AND NUTRACEUTICALS THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ BILLIONS)
    • MARKET BY FORMULATION
      • TABLE 30: GLOBAL REVENUE FOR OTC AND NUTRACEUTICALS THROUGH CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ BILLIONS)
      • FIGURE 19: GLOBAL REVENUE FOR OTC AND NUTRACEUTICALS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ BILLIONS)
      • Market Share
        • TABLE 31: GLOBAL MARKET SHARE OF OTC AND NUTRACEUTICALS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
        • FIGURE 20: GLOBAL MARKET SHARE OF OTC AND NUTRACEUTICALS THROUGH CONTRACT MANUFACTURING BY DOSAGE TYPE, 2013 (%)
  • CONTRACT MANUFACTURING OF BULK DRUGS AND DOSAGE FORMS BY APPLICATION/THERAPEUTIC AREA
    • CARDIOVASCULARS
    • ANTIBIOTICS
    • ANALGESICS
    • ONCOLOGY
    • ANTIVIRALS
    • REPRODUCTIVE DRUG PRODUCTS
    • OTHER DRUGS
    • MARKET REVENUE
      • TABLE 32: GLOBAL REVENUE FOR CONTRACT MANUFACTURING DRUGS BY THERAPEUTIC CATEGORY, THROUGH 2019 ($ MILLIONS)
      • FIGURE 21: GLOBAL REVENUE FOR CONTRACT MANUFACTURING DRUGS BY THERAPEUTIC CATEGORY, 2012-2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 33: GLOBAL MARKET SHARE OF VARIOUS THERAPEUTIC CATEGORIES IN CONTRACT MANUFACTURING, 2013 (%)
      • FIGURE 22: GLOBAL MARKET SHARE OF VARIOUS THERAPEUTIC CATEGORIES IN CONTRACT MANUFACTURING, 2013 (%)

CHAPTER 7 - MARKET ANALYSIS: CONTRACT RESEARCH

  • MARKET BY DISCIPLINE
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 34: GLOBAL REVENUE FOR CONTRACT RESEARCH BY DISCIPLINE, THROUGH 2019 ($ MILLIONS)
      • FIGURE 23: GLOBAL REVENUE FOR CONTRACT RESEARCH BY DISCIPLINE, 2012-2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 35: GLOBAL MARKET SHARE OF CONTRACT RESEARCH BY DISCIPLINE, 2013 (%)
      • FIGURE 24: GLOBAL MARKET SHARE OF CONTRACT RESEARCH BY DISCIPLINE, 2013 (%)
  • MARKET BY REGION
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 36: GLOBAL REVENUE FOR CONTRACT RESEARCH BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 25: GLOBAL REVENUE FOR CONTRACT RESEARCH MARKET BY REGION, 2012-2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 37: GLOBAL MARKET SHARE OF CONTRACT RESEARCH BY REGION, 2013 (%)
      • FIGURE 26: GLOBAL MARKET SHARE OF CONTRACT RESEARCH MARKET BY REGION, 2013 (%)
    • CONTRACT CLINICAL RESEARCH MARKET BY REGION
      • TABLE 38: GLOBAL REVENUE FOR CONTRACT CLINICAL RESEARCH BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 27: GLOBAL REVENUE FOR CONTRACT CLINICAL RESEARCH BY REGION, 2012-2019 ($ MILLIONS)
    • CONTRACT DRUG DISCOVERY MARKET BY REGION
      • TABLE 39: GLOBAL REVENUE FOR CONTRACT DRUG DISCOVERY BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 28: GLOBAL REVENUE FOR CONTRACT DRUG DISCOVERY BY REGION, 2012-2019 ($ MILLIONS)
    • CONTRACT ANALYTICAL RESEARCH MARKET BY REGION
      • TABLE 40: GLOBAL REVENUE FOR CONTRACT ANALYTICAL RESEARCH MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 29: GLOBAL REVENUE FOR CONTRACT ANALYTICAL RESEARCH MARKET BY REGION, 2012-2019 ($ MILLIONS)
    • OTHER CONTRACT RESEARCH ACTIVITIES MARKET BY REGION
      • TABLE 41: GLOBAL REVENUE FOR OTHER CONTRACT RESEARCH MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 30: GLOBAL REVENUE FOR OTHER CONTRACT RESEARCH MARKET BY REGION, 2012-2019 ($ MILLIONS)
  • MARKET BY THERAPEUTIC AREA
    • CARDIOLOGY
    • ONCOLOGY
    • INFLAMMATION AND IMMUNOLOGY
    • NEUROSCIENCE
    • VACCINES
    • OTHERS
    • MARKET REVENUE
      • TABLE 42: GLOBAL REVENUE FOR CONTRACT RESEARCH BY THERAPEUTIC AREA, THROUGH 2019 ($ MILLIONS)
      • FIGURE 31: GLOBAL REVENUE FOR CONTRACT RESEARCH BY THERAPEUTIC AREA, 2012-2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 43: GLOBAL MARKET SHARE OF CONTRACT RESEARCH BY THERAPEUTIC AREA, 2013 (%)
      • FIGURE 32: GLOBAL MARKET SHARE OF CONTRACT RESEARCH BY THERAPEUTIC AREA, 2013 (%)

CHAPTER 8 - MARKET ANALYSIS: CONTRACT PACKAGING

  • MARKET BY TYPE
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 44: GLOBAL REVENUE OF CONTRACT PACKAGING BY TYPE, THROUGH 2019 ($ MILLIONS)
      • FIGURE 33: GLOBAL REVENUE OF CONTRACT PACKAGING BY TYPE, 2012-2019 ($ MILLIONS)
    • PRIMARY CONTAINERS BY TYPE
      • TABLE 45: GLOBAL REVENUE OF PRIMARY PACKAGING BY TYPE, THROUGH 2019 ($ MILLIONS)
      • FIGURE 34: GLOBAL REVENUE OF PRIMARY PACKAGING BY TYPE, 2012-2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 46: GLOBAL MARKET SHARE OF CONTRACT PACKAGING BY TYPE, 2013 (%)
      • FIGURE 35: GLOBAL MARKET SHARE OF CONTRACT PACKAGING BY TYPE, 2013 (%)
  • MARKET BY REGION
    • MARKET OVERVIEW
    • MARKET REVENUE
      • TABLE 47: GLOBAL REVENUE OF CONTRACT PACKAGING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 36 GLOBAL REVENUE OF CONTRACT PACKAGING BY REGION, 2012-2019 ($ MILLIONS)
    • MARKET SHARE
      • TABLE 48: GLOBAL MARKET SHARE OF CONTRACT PACKAGING BY REGION, 2013 (%)
      • FIGURE 37: GLOBAL MARKET SHARE OF CONTRACT PACKAGING BY REGION, 2013 (%)
    • PRIMARY PACKAGING BY REGION
      • TABLE 49: GLOBAL REVENUE FOR PRIMARY PACKAGING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 38: GLOBAL REVENUE FOR PRIMARY PACKAGING BY REGION, 2012-2019 ($ MILLIONS)
    • SECONDARY PACKAGING BY REGION
      • TABLE 50: GLOBAL REVENUE FOR SECONDARY PACKAGING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 39: GLOBAL REVENUE FOR SECONDARY PACKAGING BY REGION, 2012-2019 ($ MILLIONS)
    • OTHER TYPES OF PACKAGING BY REGION
      • TABLE 51: GLOBAL REVENUE FOR OTHER PACKAGING BY REGION, THROUGH 2019 ($ MILLIONS)
      • FIGURE 40: GLOBAL REVENUE FOR OTHER PACKAGING BY REGION, 2012-2019 ($ MILLIONS)

CHAPTER 9 - INDUSTRY STRUCTURE

  • CONTRACT MANUFACTURING
    • MARKET LEADERS
      • TABLE 52: SERVICES PROVIDED BY CONTRACT MANUFACTURING FIRMS
    • MARKET SHARES
      • Bulk Drugs and APIS
        • TABLE 53: GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/APIs, 2013 (%)
        • FIGURE 41: GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/APIs, 2013 (%)
      • Solid-Dosage Forms
        • TABLE 54: GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2013 (%)
        • FIGURE 42: GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2013 (%)
      • Liquid Dosage Forms
        • Non-sterile
          • TABLE 55: GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING LIQUID (NON-STERILE) DOSAGE FORMS, 2013 (%)
          • FIGURE 43: GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING LIQUID (NON-STERILE) DOSAGE FORMS, 2013 (%)
        • Sterile
          • TABLE 56: GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING LIQUID (STERILE) DOSAGE FORMS, 2013 (%)
          • FIGURE 44: GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING LIQUID (STERILE) DOSAGE FORMS, 2013 (%)
      • Semisolid Dosage Forms
        • TABLE 57: GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2013 (%)
        • FIGURE 45: GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2013 (%)
  • CONTRACT RESEARCH
    • MARKET LEADERS
      • TABLE 58: SERVICES PROVIDED BY CONTRACT RESEARCH FIRMS
      • Market Shares
        • TABLE 59: GLOBAL MARKET SHARE OF CONTRACT RESEARCH COMPANIES, 2013 (%)
        • FIGURE 46: GLOBAL MARKET SHARE OF CONTRACT RESEARCH COMPANIES, 2013 (%)
  • CONTRACT PACKAGING
    • MARKET LEADERS
      • TABLE 60: SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS
      • Market Share
        • TABLE 61: GLOBAL MARKET SHARE OF CONTRACT PACKAGING COMPANIES, 2013 (%)
        • FIGURE 47: GLOBAL MARKET SHARE OF CONTRACT PACKAGING COMPANIES, 2013 (%)

CHAPTER 10 - PATENT ANALYSIS

  • PATENTS BY YEAR
    • TABLE 62: NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2013-JANUARY, 2015
    • FIGURE 48: NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2013 TO JANUARY 2015
  • PATENTS BY COMPANY
    • TABLE 63: NUMBER OF U.S. PATENTS BY COMPANY, JANUARY, 2013-JANUARY, 2015
  • PATENTS BY COUNTRY
    • TABLE 64: NUMBER OF U.S. PATENTS BY COUNTRY, 2013-JANUARY, 2015
    • FIGURE 49: NUMBER OF U.S. PATENTS BY COUNTRY, 2013 TO JANUARY 2015
    • TABLE 65: PATENT SHARES BY COUNTRY, 2013-JANUARY 2015 (%)
    • FIGURE 50: PATENT SHARES BY COUNTRY, 2013 TO JANUARY 2015 (%)
  • PATENTS BY EMPHASIS
    • TABLE 66: PATENTS BY EMPHASIS, 2013-JANUARY, 2015 (NO. OF PATENTS)
    • FIGURE 51: PATENTS BY EMPHASIS, 2013 TO JANUARY 2015 (NO. OF PATENTS)
  • PATENTS BY ASSIGNEE
    • TABLE 67: NUMBER OF PATENTS BY ASSIGNEE, 2013-JANUARY, 2015
    • FIGURE 52: NUMBER OF PATENTS BY ASSIGNEE, 2013 TO JANUARY 2015

CHAPTER 11 - CURRENT SITUATION

  • FACTORS AFFECTING THE OUTSOURCING MARKET
    • COST SAVINGS
    • DECREASING R&D SUCCESS RATES AND MOUNTING DRUG DEVELOPMENT
    • COSTS
    • INCREASING DEMAND FOR BIOSIMILARS
    • INCREASING BURDEN FROM DISEASE
    • PATENT CLIFF
      • TABLE 68: SIGNIFICANT PATENT EXPIRIES OF BIOLOGICS
    • ACCESS TO CAPABILITIES/STATE-OF-THE-ART TECHNOLOGIES
  • PHARMACEUTICAL OUTSOURCING TRENDS

CHAPTER 12 - COMPANY PROFILES

  • 3M COMPANY
  • AAIPHARMA SERVICES CORP.
  • ABBVIE CONTRACT MANUFACTURING
  • AENOVA HOLDING GMBH
  • AEROGEN LTD.
  • AJINOMOTO ALTHEA TECHNOLOGIES INC.
  • ALBANY MOLECULAR RESEARCH INC. (AMRI)
  • ALKERMES PLC
  • AMCOR LTD.
  • AMERISOURCEBERGEN CORP.
  • AMPAC FINE CHEMICALS LLC
  • APTIV SOLUTIONS
  • APTUIT INC.
  • ARADIGM CORP.
  • BAXTER INTERNATIONAL
  • BCM/BOOTS MANUFACTURING
  • BOEHRINGER INGELHEIM
  • CAMBREX CORP.
  • CANGENE CORPORATION (NOW EMERGENT BIOSOLUTIONS)
  • CATALENT PHARMA SOLUTIONS
  • CEDARBURG HAUSER PHARMACEUTICALS INC.
  • CENEXI
  • CHARLES RIVER LABORATORIES
  • CHEMBRIDGE CORP.
  • CONFAB LABORATORIES
  • CONTRACT PHARMACEUTICALS LTD.
  • CORDEN PHARMA SWITZERLAND LLC
  • COVANCE INC.
  • DECODE GENETICS
  • DISHMAN PHARMACEUTICALS AND CHEMICALS LTD.
  • DPT LABORATORIES INC.
  • DR. REDDY'S LABORATORIES
  • DSM PHARMACEUTICAL PRODUCTS INC.
  • EVOTEC AG
  • FUJIFILM DIOSYNTH BIOTECHNOLOGY
  • GIRINDUS AG
  • GLAXOSMITHKLINE
  • GRIFOLS INTERNATIONAL S.A.
  • HERON THERAPEUTICS, INC.
  • HOSPIRA
  • HOVIONE S.A
  • ICON PLC
  • INC RESEARCH, INC.
  • JUBILANT LIFE SCIENCES LTD.
  • KP PHARMACEUTICAL TECHNOLOGY INC.
  • LIGAND PHARMACEUTICALS, INC.
  • LONZA GROUP LTD
  • LYNE LABORATORIES INC.
  • MALLINCKRODT PHARMACEUTICALS
  • MEADWESTVACO CORP.
  • MIKART INC
  • NEXTPHARMA TECHNOLOGIES
  • NORWICH PHARMA SERVICES
  • NOVAVAX, INC.
  • PACKAGING COORDINATORS INC.
  • PAREXEL INTERNATIONAL CORP.
  • PATHEON INC.
  • PERRIGO COMPANY PLC
  • PFIZER CENTRESOURCE
  • PIRAMAL ENTERPRISES LTD.
  • PPD (PHARMACEUTIAL PRODUCT DEVELOPMENT LLC)
  • PRA HEALTH SCIENCES
  • QUINTILES
  • RANBAXY LABORATORIES LTD.
  • RECIPHARM AB
  • REGIS TECHNOLOGIES INC.
  • SCHOTT PHARMACEUTICAL PACKAGING
  • SKYEPHARMA PLC
  • TAKEDA PHARMACEUTICALS
  • THEOREM CLINICAL RESEARCH INC.
  • VALEANT PHARMACEUTICALS INTERNATIONAL INC.
  • VETTER PHARMA INTERNATIONAL GMBH
  • WOCKHARDT LTD.
  • WUXI APP TEC
  • ZACH SYSTEM S.P.A

CHAPTER 13 - APPENDIX

  • ABBREVIATIONS

LIST OF TABLES

  • SUMMARY TABLE GLOBAL MARKET FOR CONTRACT PHARMACEUTICAL MANUFACTURING, RESEARCH AND PACKAGING BY SEGMENT, THROUGH 2019 ($ BILLIONS)
    • TABLE 1: KEY DEVELOPMENTS IN THE HISTORY OF OUTSOURCING
    • TABLE 2: ADVANTAGES AND DISADVANTAGES OF CONTRACT MANUFACTURING
    • TABLE 3: PHARMACEUTICAL MANUFACTURERS THAT RECEIVED WARNING LETTERS, 2014
    • TABLE 4: PHARMACEUTICAL MANUFACTURERS THAT RECEIVED WARNING LETTERS, 2013
    • TABLE 5: PHARMACEUTICAL MANUFACTURERS THAT RECEIVED WARNING LETTERS, 2012
    • TABLE 6: PHARMACEUTICAL MANUFACTURERS THAT RECEIVED WARNING LETTERS, 2011
    • TABLE 7: REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, 2014
    • TABLE 8: REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, 2013
    • TABLE 9: REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, 2012
    • TABLE 10: REGULATORY APPROVALS OF CONTRACT MANUFACTURERS AND FACILITIES, 2011
    • TABLE 11: GLOBAL REVENUE FOR BULK DRUG/APIS THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 12: GLOBAL REVENUE FOR CONTRACT MANUFACTURING OF VARIOUS DOSAGE FORMS, THROUGH 2019 ($ MILLIONS)
    • TABLE 13: GLOBAL REVENUE FOR SOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 14: GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (NON-STERILE) THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 15: GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (STERILE) THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 16: GLOBAL REVENUE FOR SEMISOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 17: GLOBAL REVENUE FOR SOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ MILLIONS)
    • TABLE 18: GLOBAL MARKET SHARE OF SOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
    • TABLE 19: GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (NON-STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ MILLIONS)
    • TABLE 20: GLOBAL MARKET SHARE OF LIQUID DOSAGE FORMS (NON-STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
    • TABLE 21: GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ MILLIONS)
    • TABLE 22: GLOBAL MARKET SHARE OF LIQUID DOSAGE FORMS (STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
    • TABLE 23: GLOBAL REVENUE FOR SEMISOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ MILLIONS)
    • TABLE 24: GLOBAL MARKET SHARE OF SEMISOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
    • TABLE 25: SOME CONTRACTING COMPANIES PROVIDING DRUG-DELIVERY SYSTEMS
    • TABLE 26: GLOBAL REVENUE FOR ADVANCED DRUG DELIVERY SYSTEMS THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 27: GLOBAL REVENUE FOR ADVANCED DRUG DELIVERY SYSTEMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ MILLIONS)
    • TABLE 28: GLOBAL MARKET SHARE OF ADVANCED DRUG DELIVERY SYSTEMS THROUGH CONTRACT MANUFACTURING BY TYPE, 2013 (%)
    • TABLE 29: GLOBAL REVENUE FOR OTC AND NUTRACEUTICALS THROUGH CONTRACT MANUFACTURING BY REGION, THROUGH 2019 ($ BILLIONS)
    • TABLE 30: GLOBAL REVENUE FOR OTC AND NUTRACEUTICALS THROUGH CONTRACT MANUFACTURING BY FORMULATION, THROUGH 2019 ($ BILLIONS)
    • TABLE 31: GLOBAL MARKET SHARE OF OTC AND NUTRACEUTICALS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
    • TABLE 32: GLOBAL REVENUE FOR CONTRACT MANUFACTURING DRUGS BY THERAPEUTIC CATEGORY, THROUGH 2019 ($ MILLIONS)
    • TABLE 33: GLOBAL MARKET SHARE OF VARIOUS THERAPEUTIC CATEGORIES IN CONTRACT MANUFACTURING, 2013 (%)
    • TABLE 34: GLOBAL REVENUE FOR CONTRACT RESEARCH BY DISCIPLINE, THROUGH 2019 ($ MILLIONS)
    • TABLE 35: GLOBAL MARKET SHARE OF CONTRACT RESEARCH BY DISCIPLINE, 2013 (%)
    • TABLE 36: GLOBAL REVENUE FOR CONTRACT RESEARCH BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 37: GLOBAL MARKET SHARE OF CONTRACT RESEARCH BY REGION, 2013 (%)
    • TABLE 38: GLOBAL REVENUE FOR CONTRACT CLINICAL RESEARCH BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 39: GLOBAL REVENUE FOR CONTRACT DRUG DISCOVERY BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 40: GLOBAL REVENUE FOR CONTRACT ANALYTICAL RESEARCH MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 41: GLOBAL REVENUE FOR OTHER CONTRACT RESEARCH MARKET BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 42: GLOBAL REVENUE FOR CONTRACT RESEARCH BY THERAPEUTIC AREA, THROUGH 2019 ($ MILLIONS)
    • TABLE 43: GLOBAL MARKET SHARE OF CONTRACT RESEARCH BY THERAPEUTIC AREA, 2013 (%)
    • TABLE 44: GLOBAL REVENUE OF CONTRACT PACKAGING BY TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 45: GLOBAL REVENUE OF PRIMARY PACKAGING BY TYPE, THROUGH 2019 ($ MILLIONS)
    • TABLE 46: GLOBAL MARKET SHARE OF CONTRACT PACKAGING BY TYPE, 2013 (%)
    • TABLE 47: GLOBAL REVENUE OF CONTRACT PACKAGING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 48: GLOBAL MARKET SHARE OF CONTRACT PACKAGING BY REGION, 2013 (%)
    • TABLE 49: GLOBAL REVENUE FOR PRIMARY PACKAGING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 50: GLOBAL REVENUE FOR SECONDARY PACKAGING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 51: GLOBAL REVENUE FOR OTHER PACKAGING BY REGION, THROUGH 2019 ($ MILLIONS)
    • TABLE 52: SERVICES PROVIDED BY CONTRACT MANUFACTURING FIRMS
    • TABLE 53: GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/APIS, 2013 (%)
    • TABLE 54: GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2013 (%)
    • TABLE 55: GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING LIQUID (NON-STERILE) DOSAGE FORMS, 2013 (%)
    • TABLE 56: GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING LIQUID (STERILE) DOSAGE FORMS, 2013 (%)
    • TABLE 57: GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2013 (%)
    • TABLE 58: SERVICES PROVIDED BY CONTRACT RESEARCH FIRMS
    • TABLE 59: GLOBAL MARKET SHARE OF CONTRACT RESEARCH COMPANIES, 2013 (%)
    • TABLE 60: SERVICES PROVIDED BY CONTRACT PACKAGING FIRMS
    • TABLE 61: GLOBAL MARKET SHARE OF CONTRACT PACKAGING COMPANIES, 2013 (%)
    • TABLE 62: NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2013-JANUARY, 2015
    • TABLE 63: NUMBER OF U.S. PATENTS BY COMPANY, JANUARY, 2013-JANUARY, 2015
    • TABLE 64: NUMBER OF U.S. PATENTS BY COUNTRY, 2013-JANUARY, 2015
    • TABLE 65: PATENT SHARES BY COUNTRY, 2013-JANUARY 2015 (%)
    • TABLE 66: PATENTS BY EMPHASIS, 2013-JANUARY, 2015 (NO. OF PATENTS)
    • TABLE 67: NUMBER OF PATENTS BY ASSIGNEE, 2013-JANUARY, 2015
    • TABLE 68: SIGNIFICANT PATENT EXPIRIES OF BIOLOGICS

LIST OF FIGURES

  • SUMMARY FIGURE: GLOBAL MARKET FOR CONTRACT PHARMACEUTICAL MANUFACTURING, RESEARCH AND PACKAGING BY SEGMENT, 2012-2019 ($ BILLIONS)
    • FIGURE 1: GLOBAL REVENUE FOR BULK DRUG/APIS THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 2: GLOBAL REVENUE FOR CONTRACT MANUFACTURING OF VARIOUS DOSAGE FORMS, 2012-2019 ($ MILLIONS)
    • FIGURE 3: GLOBAL REVENUE FOR SOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 4: GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (NON-STERILE) THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 5: GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (STERILE) THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 6: GLOBAL REVENUE FOR SEMISOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 7: GLOBAL REVENUE FOR SOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ MILLIONS)
    • FIGURE 8: GLOBAL MARKET SHARE OF SOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
    • FIGURE 9: GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (NON-STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ MILLIONS)
    • FIGURE 10: GLOBAL MARKET SHARE OF LIQUID DOSAGE FORMS (NON-STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
    • FIGURE 11: GLOBAL REVENUE FOR LIQUID DOSAGE FORMS (STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ MILLIONS)
    • FIGURE 12: GLOBAL MARKET SHARE OF LIQUID DOSAGE FORMS (STERILE) THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
    • FIGURE 13: GLOBAL REVENUE FOR SEMISOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ MILLIONS)
    • FIGURE 14: GLOBAL MARKET SHARE OF SEMISOLID DOSAGE FORMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2013 (%)
    • FIGURE 15: GLOBAL REVENUE FOR ADVANCED DRUG DELIVERY SYSTEMS THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 16: GLOBAL REVENUE FOR ADVANCED DRUG DELIVERY SYSTEMS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ MILLIONS)
    • FIGURE 17: GLOBAL MARKET SHARE OF ADVANCED DRUG DELIVERY SYSTEMS THROUGH CONTRACT MANUFACTURING BY TYPE, 2013 (%)
    • FIGURE 18: GLOBAL REVENUE FOR OTC AND NUTRACEUTICALS THROUGH CONTRACT MANUFACTURING BY REGION, 2012-2019 ($ BILLIONS)
    • FIGURE 19: GLOBAL REVENUE FOR OTC AND NUTRACEUTICALS THROUGH CONTRACT MANUFACTURING BY FORMULATION, 2012-2019 ($ BILLIONS)
    • FIGURE 20: GLOBAL MARKET SHARE OF OTC AND NUTRACEUTICALS THROUGH CONTRACT MANUFACTURING BY DOSAGE TYPE, 2013 (%)
    • FIGURE 21: GLOBAL REVENUE FOR CONTRACT MANUFACTURING DRUGS BY THERAPEUTIC CATEGORY, 2012-2019 ($ MILLIONS)
    • FIGURE 22: GLOBAL MARKET SHARE OF VARIOUS THERAPEUTIC CATEGORIES IN CONTRACT MANUFACTURING, 2013 (%)
    • FIGURE 23: GLOBAL REVENUE FOR CONTRACT RESEARCH BY DISCIPLINE, 2012-2019 ($ MILLIONS)
    • FIGURE 24: GLOBAL MARKET SHARE OF CONTRACT RESEARCH BY DISCIPLINE, 2013 (%)
    • FIGURE 25: GLOBAL REVENUE FOR CONTRACT RESEARCH MARKET BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 26: GLOBAL MARKET SHARE OF CONTRACT RESEARCH MARKET BY REGION, 2013 (%)
    • FIGURE 27: GLOBAL REVENUE FOR CONTRACT CLINICAL RESEARCH BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 28: GLOBAL REVENUE FOR CONTRACT DRUG DISCOVERY BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 29: GLOBAL REVENUE FOR CONTRACT ANALYTICAL RESEARCH MARKET BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 30: GLOBAL REVENUE FOR OTHER CONTRACT RESEARCH MARKET BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 31: GLOBAL REVENUE FOR CONTRACT RESEARCH BY THERAPEUTIC AREA, 2012-2019 ($ MILLIONS)
    • FIGURE 32: GLOBAL MARKET SHARE OF CONTRACT RESEARCH BY THERAPEUTIC AREA, 2013 (%)
    • FIGURE 33: GLOBAL REVENUE OF CONTRACT PACKAGING BY TYPE, 2012-2019 ($ MILLIONS)
    • FIGURE 34: GLOBAL REVENUE OF PRIMARY PACKAGING BY TYPE, 2012-2019 ($ MILLIONS)
    • FIGURE 35: GLOBAL MARKET SHARE OF CONTRACT PACKAGING BY TYPE, 2013 (%)
    • FIGURE 36: GLOBAL REVENUE OF CONTRACT PACKAGING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 37: GLOBAL MARKET SHARE OF CONTRACT PACKAGING BY REGION, 2013 (%)
    • FIGURE 38: GLOBAL REVENUE FOR PRIMARY PACKAGING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 39: GLOBAL REVENUE FOR SECONDARY PACKAGING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 40: GLOBAL REVENUE FOR OTHER PACKAGING BY REGION, 2012-2019 ($ MILLIONS)
    • FIGURE 41: GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING BULK DRUGS/APIS, 2013 (%)
    • FIGURE 42: GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING SOLID DOSAGE FORMS, 2013 (%)
    • FIGURE 43: GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING LIQUID (NON-STERILE) DOSAGE FORMS, 2013 (%)
    • FIGURE 44: GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING LIQUID (STERILE) DOSAGE FORMS, 2013 (%)
    • FIGURE 45: GLOBAL MARKET SHARE OF CONTRACT MANUFACTURING COMPANIES PROVIDING SEMISOLID DOSAGE FORMS, 2013 (%)
    • FIGURE 46: GLOBAL MARKET SHARE OF CONTRACT RESEARCH COMPANIES, 2013 (%)
    • FIGURE 47: GLOBAL MARKET SHARE OF CONTRACT PACKAGING COMPANIES, 2013 (%)
    • FIGURE 48: NUMBER OF SIGNIFICANT PATENTS BY YEAR, 2013 TO JANUARY 2015
    • FIGURE 49: NUMBER OF U.S. PATENTS BY COUNTRY, 2013 TO JANUARY 2015
    • FIGURE 50: PATENT SHARES BY COUNTRY, 2013 TO JANUARY 2015 (%)
    • FIGURE 51: PATENTS BY EMPHASIS, 2013 TO JANUARY 2015 (NO. OF PATENTS)
    • FIGURE 52: NUMBER OF PATENTS BY ASSIGNEE, 2013 TO JANUARY 2015 172
Back to Top